ISOPROPYL ALCOHOL SPRAY

ISOPROPYL ALCOHOL SPRAY was reported 3463 times

ISOPROPYL ALCOHOL SPRAY is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GRIP STRENGTH 120 0.5240
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY NEGATIVE 1 0.5000
2 CATHETER CULTURE 1 0.5000
3 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 268 0.4012
4 LUPUS VULGARIS 469 0.3722
5 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 169 0.3012
6 SWOLLEN JOINT COUNT 74 0.2960
7 DEEP VEIN THROMBOSIS POSTOPERATIVE 537 0.2681
8 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 530 0.2555
9 SWOLLEN JOINT COUNT INCREASED 814 0.2550
10 RHEUMATIC FEVER 1112 0.2492
11 C-REACTIVE PROTEIN 224 0.2416
12 DISLOCATION OF VERTEBRA 516 0.2260
13 FACET JOINT SYNDROME 730 0.2240
14 X-RAY ABNORMAL 397 0.2218
15 HEPATIC ENZYME 32 0.2148
16 ACQUIRED PORPHYRIA 14 0.1972
17 RETINITIS 327 0.1891
18 DUODENAL ULCER PERFORATION 1364 0.1832
19 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1206 0.1682
20 RHEUMATOID FACTOR POSITIVE 963 0.1666
21 MUSCLE INJURY 1261 0.1520
22 PORPHYRIA ACUTE 214 0.1491
23 HELICOBACTER INFECTION 1468 0.1427
24 FOLLICULITIS 1438 0.1370
25 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 881 0.1355
26 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, MIXED TYPE 3 0.1304
27 PERIPHERAL VENOUS DISEASE 518 0.1267
28 C-REACTIVE PROTEIN ABNORMAL 773 0.1204
29 PEMPHIGUS 1495 0.1195
30 HAND DEFORMITY 1472 0.1121
31 BONE EROSION 358 0.1011
32 LABOUR AUGMENTATION 1 0.1000
33 CATHETER SITE PARAESTHESIA 1 0.1000
34 SERONEGATIVE ARTHRITIS 106 0.0925
35 BREAST CANCER STAGE III 591 0.0912
36 PERICARDITIS 1454 0.0865
37 LIP DRY 728 0.0801
38 HYPERCHOLESTEROLAEMIA 750 0.0776
39 SYNOVITIS 1383 0.0766
40 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 8 0.0762
41 ONYCHOMADESIS 316 0.0752
42 GRIP STRENGTH DECREASED 662 0.0751
43 JOINT RANGE OF MOTION DECREASED 1004 0.0748
44 IRRITABLE BOWEL SYNDROME 1457 0.0679
45 GLOSSODYNIA 1490 0.0665
46 ONYCHOMYCOSIS 292 0.0665
47 WOUND INFECTION 706 0.0644
48 HYPOCHOLESTEROLAEMIA 21 0.0595
49 SPINAL FUSION FRACTURE 1 0.0556
50 DRUG TOLERANCE DECREASED 156 0.0555
51 SWOLLEN JOINT COUNT ABNORMAL 1 0.0526
52 BURSITIS 633 0.0521
53 AUTOIMMUNE DISORDER 503 0.0516
54 WOUND 1429 0.0511
55 GAIT APRAXIA 2 0.0488
56 PUSTULAR PSORIASIS 167 0.0486
57 FIBROMYALGIA 1113 0.0457
58 WALKING AID USER 301 0.0456
59 IMPAIRED HEALING 1454 0.0442
60 MATERNAL EXPOSURE TIMING UNSPECIFIED 164 0.0436
61 SYSTEMIC LUPUS ERYTHEMATOSUS 1461 0.0411
62 LIVER INJURY 998 0.0406
63 FINGER DEFORMITY 195 0.0402
64 LIVE BIRTH 322 0.0385
65 EXOSTOSIS 349 0.0382
66 EYE INJURY 115 0.0378
67 BLEPHAROSPASM 238 0.0378
68 TYPE 2 DIABETES MELLITUS 1267 0.0376
69 LUPUS-LIKE SYNDROME 333 0.0367
70 TENDER JOINT COUNT 3 0.0357
71 ULCER HAEMORRHAGE 237 0.0350
72 RASH VESICULAR 166 0.0343
73 OBESITY 540 0.0339
74 PULMONARY FIBROSIS 649 0.0338
75 SCIATICA 539 0.0338
76 NAIL DISORDER 291 0.0332
77 CARDIAC MONITORING ABNORMAL 1 0.0323
78 OSMOLAR GAP INCREASED 3 0.0297
79 CONTRAINDICATED PRODUCT ADMINISTERED 900 0.0297
80 PSORIATIC ARTHROPATHY 1201 0.0296
81 FOOT DEFORMITY 307 0.0277
82 LOWER LIMB FRACTURE 531 0.0276
83 RED BLOOD CELL SEDIMENTATION RATE INCREASED 305 0.0275
84 LOWER RESPIRATORY TRACT INFECTION 1227 0.0270
85 PRESCRIBED OVERDOSE 491 0.0253
86 JOINT DISLOCATION 268 0.0253
87 HIP ARTHROPLASTY 386 0.0252
88 BREAST CANCER STAGE II 208 0.0250
89 PRODUCT LABEL CONFUSION 143 0.0245
90 OVERLAP SYNDROME 17 0.0243
91 SYNOVIAL FLUID ANALYSIS 2 0.0230
92 GAIT INABILITY 763 0.0228
93 BLISTER 1274 0.0227
94 ARTHROPATHY 1254 0.0225
95 INFUSION RELATED REACTION 1457 0.0220
96 BLOOD CHOLESTEROL INCREASED 1012 0.0217
97 ILL-DEFINED DISORDER 1276 0.0210
98 HEPATIC ENZYME INCREASED 1429 0.0209
99 STOMATITIS 1258 0.0207
100 GENERAL SYMPTOM 153 0.0204
101 CONGENITAL ANOMALY 155 0.0200
102 TISSUE RUPTURE 1 0.0200
103 BACK INJURY 215 0.0198
104 PRESCRIBED UNDERDOSE 390 0.0195
105 NIGHT SWEATS 616 0.0191
106 HEPATIC CIRRHOSIS 359 0.0191
107 DISCOMFORT 1163 0.0190
108 MYOSITIS 171 0.0190
109 INJURY 1334 0.0190
110 SPONDYLITIS 69 0.0190
111 THERAPEUTIC PRODUCT EFFECT DECREASED 824 0.0184
112 WHEEZING 1039 0.0175
113 OSTEOARTHRITIS 735 0.0173
114 SLEEP DISORDER 1212 0.0172
115 KNEE ARTHROPLASTY 356 0.0169
116 COELIAC DISEASE 163 0.0166
117 PERFORATION 13 0.0161
118 ROAD TRAFFIC ACCIDENT 666 0.0159
119 OEDEMA 850 0.0157
120 MOBILITY DECREASED 1109 0.0154
121 C-REACTIVE PROTEIN INCREASED 561 0.0154
122 ANTIPHOSPHOLIPID ANTIBODIES 3 0.0154
123 SLEEP DISORDER THERAPY 3 0.0152
124 APPLICATION SITE CELLULITIS 1 0.0149
125 DELIRIUM 516 0.0149
126 SWELLING 1385 0.0148
127 LIVER DISORDER 649 0.0146
128 LIVER FUNCTION TEST INCREASED 310 0.0144
129 SPINAL FUSION SURGERY 57 0.0140
130 INFLAMMATION 704 0.0136
131 NORMAL NEWBORN 74 0.0136
132 DISABILITY 256 0.0129
133 LUNG DISORDER 616 0.0126
134 ADVERSE REACTION 165 0.0124
135 JOINT SWELLING 1478 0.0122
136 RHEUMATOID ARTHRITIS 1379 0.0121
137 GASTROINTESTINAL DISORDER 1060 0.0118
138 MUSCULOSKELETAL PAIN 598 0.0114
139 JOINT STIFFNESS 296 0.0113
140 EAR INFECTION 300 0.0113
141 MUSCULOSKELETAL STIFFNESS 984 0.0112
142 TASTE DISORDER 225 0.0111
143 SYNOVIAL DISORDER 5 0.0110
144 DRUG-INDUCED LIVER INJURY 343 0.0109
145 GENERAL PHYSICAL HEALTH DETERIORATION 1255 0.0108
146 SINUSITIS 1108 0.0108
147 PREGNANCY 216 0.0108
148 CONTUSION 1034 0.0107
149 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 175 0.0103
150 BACK DISORDER 165 0.0101
151 INFUSION SITE REACTION 30 0.0100
152 DRUG INTOLERANCE 964 0.0100
153 MATERNAL EXPOSURE DURING PREGNANCY 849 0.0095
154 ANALGESIC THERAPY 3 0.0093
155 HYPERTROPHIC SCAR 1 0.0092
156 TREATMENT FAILURE 756 0.0091
157 DRY MOUTH 736 0.0091
158 BRACHIAL PLEXOPATHY 2 0.0090
159 TENOSYNOVITIS STENOSANS 5 0.0090
160 DRUG THERAPY 3 0.0088
161 BLOODY DISCHARGE 10 0.0087
162 THERAPY NON-RESPONDER 390 0.0087
163 INFECTION 1237 0.0085
164 CONFUSIONAL STATE 1367 0.0084
165 DYSPEPSIA 810 0.0082
166 EPILEPSY 251 0.0082
167 INTENTIONAL PRODUCT USE ISSUE 719 0.0082
168 WEIGHT FLUCTUATION 85 0.0081
169 AMNESIA 519 0.0080
170 FREQUENT BOWEL MOVEMENTS 213 0.0079
171 APPENDICOLITH 3 0.0078
172 HYPERSENSITIVITY 1429 0.0077
173 ABDOMINAL DISCOMFORT 1290 0.0077
174 PERIPHERAL SWELLING 1183 0.0077
175 OSTEOPOROSIS 314 0.0076
176 ILIAC ARTERY STENOSIS 1 0.0076
177 MIGRAINE 697 0.0073
178 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 124 0.0072
179 MYCETOMA MYCOTIC 1 0.0072
180 JOINT DESTRUCTION 11 0.0071
181 NASOPHARYNGITIS 1284 0.0070
182 HYPOAESTHESIA 1042 0.0070
183 HEPATITIS 176 0.0069
184 ALOPECIA 1324 0.0067
185 URTICARIA 1107 0.0066
186 MEDICATION ERROR 346 0.0062
187 EXPOSURE DURING PREGNANCY 380 0.0061
188 WEIGHT INCREASED 1286 0.0057
189 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 268 0.0056
190 HYPERTENSION 1170 0.0055
191 MEMORY IMPAIRMENT 737 0.0054
192 SPONDYLOLYSIS 1 0.0053
193 HYPERTRANSAMINASAEMIA 37 0.0053
194 DEATH NEONATAL 7 0.0050
195 RECTAL HAEMORRHAGE 215 0.0050
196 ASTHMA 564 0.0050
197 COLITIS ULCERATIVE 222 0.0050
198 STARVATION KETOACIDOSIS 1 0.0050
199 RESPIRATORY DISORDER 148 0.0049
200 LABORATORY TEST ABNORMAL 144 0.0049
201 NAIL OPERATION 2 0.0048
202 INTERNATIONAL NORMALISED RATIO FLUCTUATION 10 0.0048
203 ADVERSE EVENT 429 0.0047
204 OSTEORADIONECROSIS 1 0.0045
205 OEDEMA PERIPHERAL 536 0.0044
206 EAR PAIN 85 0.0044
207 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 298 0.0042
208 MUSCLE SPASTICITY 51 0.0041
209 WHITE BLOOD CELL COUNT INCREASED 159 0.0041
210 ABDOMINAL PAIN UPPER 852 0.0041
211 BREAST CANCER STAGE I 38 0.0041
212 MUSCULAR WEAKNESS 457 0.0040
213 ARTHRITIS 314 0.0040
214 CHEST PAIN 737 0.0040
215 INSOMNIA 1052 0.0039
216 VIBRATORY SENSE INCREASED 1 0.0039
217 STEROID WITHDRAWAL SYNDROME 4 0.0039
218 UPPER RESPIRATORY TRACT INFECTION 179 0.0039
219 RED BLOOD CELL SEDIMENTATION RATE DECREASED 1 0.0038
220 EXTRADURAL ABSCESS 3 0.0038
221 CONDITION AGGRAVATED 1144 0.0038
222 INJECTION SITE REACTION 253 0.0037
223 DAIRY INTOLERANCE 1 0.0036
224 PANCREATITIS 187 0.0035
225 NECK PAIN 196 0.0035
226 FLUID RETENTION 177 0.0035
227 PARAESTHESIA 534 0.0034
228 MUSCLE SPASMS 617 0.0034
229 PRODUCT USE ISSUE 625 0.0033
230 DECREASED APPETITE 768 0.0033
231 RASH 1438 0.0033
232 FEELING HOT 202 0.0033
233 RESPIRATORY FUME INHALATION DISORDER 1 0.0032
234 PYREXIA 1113 0.0032
235 ALLERGY TO CHEMICALS 4 0.0032
236 GAIT DISTURBANCE 607 0.0032
237 SCLERITIS 5 0.0031
238 GASTROOESOPHAGEAL REFLUX DISEASE 250 0.0031
239 ADVERSE DRUG REACTION 275 0.0031
240 PRURITUS 1168 0.0030
241 DEPRESSION 691 0.0030
242 LYME DISEASE 10 0.0030
243 ALCOHOL POISONING 8 0.0030
244 ARTHRALGIA 1218 0.0029
245 PAIN IN EXTREMITY 850 0.0029
246 PRODUCT USE IN UNAPPROVED INDICATION 705 0.0028
247 TRYPTASE INCREASED 2 0.0028
248 JOINT ARTHROPLASTY 5 0.0028
249 THERAPEUTIC RESPONSE DECREASED 167 0.0028
250 UNDERDOSE 199 0.0027
251 VISUAL IMPAIRMENT 328 0.0026
252 ASPARTATE AMINOTRANSFERASE ABNORMAL 4 0.0026
253 DRUG TOLERANCE 13 0.0026
254 PNEUMONIA 804 0.0025
255 DENTAL FISTULA 1 0.0024
256 PAIN 1429 0.0023
257 DIABETIC HYPEROSMOLAR COMA 1 0.0023
258 PSORIASIS 299 0.0023
259 BODY TEMPERATURE INCREASED 46 0.0023
260 DYSPNOEA 1265 0.0022
261 HEPATIC ENZYME DECREASED 1 0.0022
262 IRON DEFICIENCY 10 0.0022
263 GENERAL ANAESTHESIA 1 0.0022
264 VOMITING 1036 0.0022
265 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 5 0.0022
266 METAPLASIA 1 0.0021
267 BLOOD CHOLESTEROL 1 0.0021
268 ABDOMINAL DISTENSION 218 0.0021
269 MALAISE 883 0.0020
270 BRONCHITIS 147 0.0020
271 WEIGHT DECREASED 540 0.0019
272 TACHYCARDIA 171 0.0019
273 POLYARTHRITIS 10 0.0019
274 CUSHINGOID 6 0.0019
275 ANXIETY 528 0.0019
276 DUODENAL ULCER 13 0.0018
277 RHEUMATOID NODULE 5 0.0018
278 PLEURITIC PAIN 5 0.0018
279 APNOEIC ATTACK 1 0.0018
280 RASH PRURITIC 96 0.0018
281 FATIGUE 1374 0.0018
282 ABDOMINAL PAIN 404 0.0017
283 CHEMICAL BURN 2 0.0017
284 PALMAR ERYTHEMA 2 0.0017
285 CREPITATIONS 5 0.0017
286 BRAIN DEATH 5 0.0016
287 HEADACHE 1010 0.0016
288 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 2 0.0016
289 INTERVERTEBRAL DISCITIS 3 0.0016
290 DIZZINESS 792 0.0016
291 FOETAL EXPOSURE DURING PREGNANCY 129 0.0016
292 PRODUCT QUALITY ISSUE 215 0.0016
293 ASTHENIA 587 0.0016
294 NEUROPATHIC ARTHROPATHY 1 0.0015
295 ANTINUCLEAR ANTIBODY POSITIVE 5 0.0015
296 POSTOPERATIVE ADHESION 1 0.0015
297 PROTEIN TOTAL INCREASED 4 0.0015
298 DIARRHOEA 918 0.0014
299 HYPERPHOSPHATAEMIA 3 0.0014
300 INFECTION IN AN IMMUNOCOMPROMISED HOST 1 0.0014
301 OFF LABEL USE 1174 0.0013
302 ARTERIAL INJURY 1 0.0013
303 PREGNANCY AFTER POST COITAL CONTRACEPTION 3 0.0013
304 NAUSEA 1050 0.0013
305 HOSPITALISATION 192 0.0012
306 CHEMICAL INJURY 1 0.0012
307 LEUKOPENIA 61 0.0012
308 CARDIAC STRESS TEST ABNORMAL 1 0.0012
309 FUNCTIONAL GASTROINTESTINAL DISORDER 4 0.0012
310 INCORRECT PRODUCT ADMINISTRATION DURATION 25 0.0012
311 THROMBOCYTOPENIA 125 0.0011
312 PRIMARY SEQUESTRUM 1 0.0011
313 BLOOD PHOSPHORUS INCREASED 3 0.0011
314 SYNOVIAL CYST 5 0.0011
315 ULCER 17 0.0011
316 BUNDLE BRANCH BLOCK 1 0.0011
317 HEPATIC NECROSIS 4 0.0011
318 SACROILIITIS 2 0.0011
319 WOUND SECRETION 4 0.0010
320 MASTOIDITIS 1 0.0010
321 DUODENAL PERFORATION 1 0.0010
322 ADMINISTRATION SITE EXTRAVASATION 1 0.0010
323 ABSCESS JAW 1 0.0010
324 RESPIRATORY TRACT INFECTION 25 0.0010
325 SPINAL DISORDER 9 0.0009
326 SINUSITIS BACTERIAL 1 0.0009
327 BURNS THIRD DEGREE 1 0.0009
328 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 1 0.0009
329 VASCULAR CALCIFICATION 1 0.0009
330 ASPIRATION 10 0.0009
331 ADRENAL INSUFFICIENCY 11 0.0009
332 PERIRECTAL ABSCESS 1 0.0009
333 HALO VISION 1 0.0009
334 IMMUNODEFICIENCY 13 0.0009
335 DYSPLASIA 1 0.0008
336 DRUG INEFFECTIVE 1089 0.0008
337 PRODUCT PACKAGING CONFUSION 2 0.0008
338 EJECTION FRACTION ABNORMAL 1 0.0008
339 SECRETION DISCHARGE 10 0.0008
340 ADJUSTMENT DISORDER 1 0.0008
341 PLATELET COUNT INCREASED 10 0.0008
342 RESPIRATORY ACIDOSIS 3 0.0008
343 AREFLEXIA 2 0.0007
344 JOINT EFFUSION 5 0.0007
345 TENOSYNOVITIS 2 0.0007
346 SKIN ATROPHY 4 0.0007
347 HYPERTHERMIA MALIGNANT 1 0.0007
348 INTERMITTENT CLAUDICATION 1 0.0006
349 FALL 210 0.0006
350 SPINAL CORD DISORDER 1 0.0006
351 SKIN WOUND 1 0.0006
352 INTENTIONAL PRODUCT MISUSE 51 0.0006
353 HYPOPNOEA 2 0.0006
354 FORMICATION 4 0.0006
355 BURNS SECOND DEGREE 1 0.0006
356 TREATMENT NONCOMPLIANCE 31 0.0006
357 LIVER TRANSPLANT REJECTION 1 0.0006
358 NODULE 7 0.0005
359 FLANK PAIN 5 0.0005
360 OVERDOSE 115 0.0005
361 GUN SHOT WOUND 1 0.0005
362 LYMPHADENOPATHY MEDIASTINAL 1 0.0005
363 BLOOD URIC ACID INCREASED 3 0.0005
364 ATELECTASIS 5 0.0005
365 SPINAL CORD COMPRESSION 2 0.0005
366 EMPYEMA 1 0.0005
367 OSTEOLYSIS 1 0.0005
368 ANAPHYLACTOID REACTION 2 0.0005
369 TENDERNESS 5 0.0005
370 ATRIAL TACHYCARDIA 1 0.0005
371 CATHETER SITE ERYTHEMA 1 0.0005
372 DEREALISATION 1 0.0005
373 JAW FRACTURE 1 0.0005
374 APPLICATION SITE SCAB 1 0.0005
375 PSEUDOMEMBRANOUS COLITIS 1 0.0004
376 WRONG PRODUCT ADMINISTERED 3 0.0004
377 VASCULAR DEVICE INFECTION 2 0.0004
378 BREAKTHROUGH PAIN 1 0.0004
379 THERMAL BURN 3 0.0004
380 VOLVULUS 1 0.0004
381 GASTROINTESTINAL TOXICITY 2 0.0004
382 DERMAL CYST 1 0.0004
383 APPLICATION SITE BURN 2 0.0004
384 HYPOPHOSPHATAEMIA 3 0.0004
385 MULTIPLE DRUG OVERDOSE 2 0.0004
386 CHEMICAL BURN OF SKIN 1 0.0004
387 STAPHYLOCOCCAL INFECTION 13 0.0004
388 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 2 0.0004
389 ACTINIC KERATOSIS 1 0.0004
390 BLOOD LACTIC ACID INCREASED 2 0.0004
391 MYASTHENIA GRAVIS 3 0.0004
392 MACULE 1 0.0004
393 ACCIDENTAL OVERDOSE 13 0.0004
394 VITAMIN B12 DECREASED 1 0.0003
395 LUMBAR SPINAL STENOSIS 1 0.0003
396 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
397 APPENDICITIS 3 0.0003
398 NO ADVERSE EVENT 58 0.0003
399 INFUSION SITE PRURITUS 1 0.0003
400 NON-CARDIAC CHEST PAIN 1 0.0003
401 HEPATOTOXICITY 7 0.0003
402 SUBSTANCE USE DISORDER 1 0.0003
403 MULTIPLE DRUG OVERDOSE INTENTIONAL 1 0.0003
404 CLOSTRIDIAL INFECTION 1 0.0003
405 MATERNAL EXPOSURE BEFORE PREGNANCY 2 0.0003
406 SKIN REACTION 4 0.0003
407 PULMONARY TOXICITY 2 0.0003
408 SINUS TACHYCARDIA 4 0.0003
409 VENTRICULAR FIBRILLATION 3 0.0003
410 CONJUNCTIVITIS 5 0.0003
411 HYDRONEPHROSIS 2 0.0003
412 PHOTOPHOBIA 5 0.0003
413 FEELING JITTERY 5 0.0003
414 HYPOKALAEMIA 12 0.0003
415 BACK PAIN 60 0.0003
416 APNOEA 2 0.0003
417 MUSCLE DISORDER 2 0.0002
418 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 1 0.0002
419 BRAIN OEDEMA 3 0.0002
420 ABSCESS LIMB 1 0.0002
421 INTERVERTEBRAL DISC DISORDER 1 0.0002
422 IMPAIRED WORK ABILITY 5 0.0002
423 CATHETERISATION CARDIAC 1 0.0002
424 QUALITY OF LIFE DECREASED 3 0.0002
425 MENINGITIS ASEPTIC 1 0.0002
426 ACUTE HEPATIC FAILURE 3 0.0002
427 ABDOMINAL HERNIA 1 0.0002
428 HAEMOGLOBIN INCREASED 1 0.0002
429 RESPIRATORY DISTRESS 6 0.0002
430 NEPHROGENIC ANAEMIA 1 0.0002
431 ARTHRITIS INFECTIVE 1 0.0002
432 ROSACEA 1 0.0002
433 DEFORMITY 2 0.0002
434 SUSPECTED SUICIDE 1 0.0002
435 DEATH 183 0.0002
436 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6 0.0002
437 CARDIOGENIC SHOCK 3 0.0002
438 PARAESTHESIA ORAL 3 0.0002
439 INFLAMMATORY BOWEL DISEASE 2 0.0002
440 BREATH SOUNDS ABNORMAL 1 0.0002
441 DIABETIC NEUROPATHY 1 0.0002
442 HEPATIC ENZYME ABNORMAL 1 0.0002
443 HYPOTONIA 2 0.0002
444 KLEBSIELLA INFECTION 1 0.0002
445 VAGINAL DISCHARGE 2 0.0002
446 ENDOCARDITIS 1 0.0002
447 UNRESPONSIVE TO STIMULI 5 0.0002
448 SKIN ULCER 5 0.0002
449 FOETAL DEATH 1 0.0002
450 MALABSORPTION 1 0.0002
451 APPLICATION SITE ERYTHEMA 5 0.0002
452 SENSITIVITY TO WEATHER CHANGE 1 0.0002
453 DEPRESSED MOOD 10 0.0002
454 ANAL FISTULA 1 0.0002
455 INTENTIONAL OVERDOSE 12 0.0002
456 BRUXISM 1 0.0002
457 MENTAL STATUS CHANGES 5 0.0002
458 MULTI-ORGAN FAILURE 3 0.0002
459 MUSCLE TWITCHING 4 0.0002
460 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 31 0.0002
461 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
462 DECREASED INTEREST 1 0.0002
463 SYMPTOM RECURRENCE 1 0.0002
464 GANGRENE 1 0.0002
465 RESPIRATORY DEPRESSION 2 0.0002
466 DRUG ABUSER 1 0.0002
467 PIGMENTATION DISORDER 1 0.0002
468 BACTERIAL INFECTION 3 0.0002
469 HYPOCALCAEMIA 3 0.0002
470 METABOLIC ACIDOSIS 5 0.0002
471 PROCTALGIA 1 0.0002
472 ANGINA UNSTABLE 1 0.0002
473 TENDON DISORDER 1 0.0002
474 MENINGITIS 1 0.0001
475 PRODUCT LABEL ISSUE 1 0.0001
476 BLOOD TESTOSTERONE DECREASED 1 0.0001
477 PRODUCT PREPARATION ERROR 3 0.0001
478 CROHN'S DISEASE 1 0.0001
479 ECCHYMOSIS 1 0.0001
480 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 8 0.0001
481 ONYCHOCLASIS 1 0.0001
482 LYMPHOEDEMA 1 0.0001
483 INTENTIONAL DRUG MISUSE 3 0.0001
484 APPLICATION SITE REACTION 1 0.0001
485 PAPULE 1 0.0001
486 DIVERTICULUM 1 0.0001
487 RED BLOOD CELL COUNT DECREASED 4 0.0001
488 TOXICITY TO VARIOUS AGENTS 23 0.0001
489 ASCITES 4 0.0001
490 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
491 PEMPHIGOID 1 0.0001
492 HAEMODYNAMIC INSTABILITY 1 0.0001
493 ACIDOSIS 1 0.0001
494 RENAL FAILURE CHRONIC 1 0.0001
495 OCULAR HYPERAEMIA 6 0.0001
496 RENAL CYST 1 0.0001
497 ATRIAL FLUTTER 1 0.0001
498 HAEMORRHAGE 13 0.0001
499 INTERSTITIAL LUNG DISEASE 6 0.0001
500 NEURALGIA 3 0.0001
501 SUBSTANCE ABUSE 1 0.0001
502 LOSS OF CONSCIOUSNESS 15 0.0001
503 VITAMIN D DECREASED 1 0.0001
504 ANURIA 1 0.0001
505 NEOPLASM PROGRESSION 4 0.0001
506 SPINAL OSTEOARTHRITIS 1 0.0001
507 RESPIRATORY RATE INCREASED 1 0.0001
508 GASTROENTERITIS VIRAL 2 0.0001
509 OSTEOMYELITIS 2 0.0001
510 HIDRADENITIS 1 0.0001
511 IRON DEFICIENCY ANAEMIA 1 0.0001
512 DEEP VEIN THROMBOSIS 7 0.0001
513 EYE PAIN 6 0.0001
514 POISONING DELIBERATE 1 0.0001
515 RENAL TUBULAR NECROSIS 1 0.0001
516 DRY EYE 5 0.0001
517 BRAIN INJURY 1 0.0001
518 HYPOTENSION 20 0.0001
519 THROMBOSIS 8 0.0001
520 HYPOTHERMIA 1 0.0001
521 TEMPERATURE INTOLERANCE 1 0.0001
522 BONE DENSITY DECREASED 3 0.0001
523 JOINT INJURY 2 0.0001
524 SKIN LACERATION 1 0.0001
525 INJECTION SITE NODULE 1 0.0001
526 RASH MACULO-PAPULAR 2 0.0001
527 NEOPLASM MALIGNANT 6 0.0001
528 SKIN INFECTION 1 0.0001
529 SCAB 1 0.0001
530 EYE IRRITATION 5 0.0001
531 BLOOD IRON DECREASED 1 0.0001
532 BACTERAEMIA 1 0.0001
533 PRESYNCOPE 2 0.0001
534 CARDIOMEGALY 1 0.0001
535 SEPSIS 9 0.0001
536 APPLICATION SITE IRRITATION 1 0.0001
537 SWELLING FACE 5 0.0001
538 IMMUNE SYSTEM DISORDER 1 0.0001
539 THROAT TIGHTNESS 2 0.0001
540 WHITE BLOOD CELL COUNT DECREASED 8 0.0001
541 PERIPHERAL COLDNESS 1 0.0001
542 RESPIRATORY ARREST 2 0.0001
543 COMPLETED SUICIDE 6 0.0001
544 MASS 1 0.0001
545 HYPONATRAEMIA 4 0.0001
546 PARALYSIS 1 0.0001
547 LETHARGY 4 0.0001
548 HYPERTHYROIDISM 1 0.0001
549 PULMONARY MASS 1 0.0001
550 HYPOAESTHESIA ORAL 1 0.0001
551 DEVICE RELATED INFECTION 1 0.0001
552 LIMB DISCOMFORT 2 0.0001
553 MUSCULOSKELETAL CHEST PAIN 1 0.0001
554 BASAL CELL CARCINOMA 1 0.0001
555 PRODUCT USE COMPLAINT 1 0.0001
556 RESPIRATORY TRACT CONGESTION 1 0.0001
557 MOVEMENT DISORDER 2 0.0001
558 METASTASES TO BONE 1 0.0001
559 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
560 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
561 EXPIRED PRODUCT ADMINISTERED 2 0.0001
562 LIP SWELLING 2 0.0001
563 BLOOD UREA INCREASED 1 0.0001
564 SKIN EXFOLIATION 5 0.0001
565 GASTRIC DISORDER 2 0.0001
566 MUSCULOSKELETAL DISCOMFORT 1 0.0001
567 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
568 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
569 HEAD DISCOMFORT 1 0.0001
570 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
571 BONE DISORDER 1 0.0001
572 END STAGE RENAL DISEASE 1 0.0001
573 ANAPHYLACTIC REACTION 3 0.0001
574 HEPATIC STEATOSIS 1 0.0001
575 BLOOD SODIUM DECREASED 1 0.0001
576 FOOT FRACTURE 1 0.0001
577 GASTRIC ULCER 1 0.0001
578 PRODUCT SUBSTITUTION ISSUE 3 0.0001
579 HERNIA 1 0.0001
580 ABNORMAL BEHAVIOUR 2 0.0001
581 UPPER LIMB FRACTURE 1 0.0001
582 SPINAL FRACTURE 1 0.0000
583 RIB FRACTURE 1 0.0000
584 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
585 SEPTIC SHOCK 2 0.0000
586 PRODUCT DISPENSING ERROR 1 0.0000
587 PRODUCT PRESCRIBING ISSUE 1 0.0000
588 TRANSAMINASES INCREASED 1 0.0000
589 APPLICATION SITE PRURITUS 1 0.0000
590 SEIZURE 5 0.0000
591 COMA 2 0.0000
592 LOCALISED INFECTION 1 0.0000
593 MENTAL IMPAIRMENT 1 0.0000
594 AGITATION 3 0.0000
595 OSTEONECROSIS OF JAW 1 0.0000
596 PNEUMONIA ASPIRATION 1 0.0000
597 SOMNOLENCE 8 0.0000
598 CHRONIC KIDNEY DISEASE 3 0.0000
599 HAEMATEMESIS 1 0.0000
600 DIABETES MELLITUS 3 0.0000
601 ACUTE KIDNEY INJURY 6 0.0000
602 GASTRITIS 1 0.0000
603 FEAR 1 0.0000
604 PALLOR 1 0.0000
605 DRUG ABUSE 3 0.0000
606 PAIN IN JAW 1 0.0000
607 INTENTIONAL DOSE OMISSION 1 0.0000
608 DYSPHONIA 2 0.0000
609 ERYTHEMA 7 0.0000
610 RENAL INJURY 1 0.0000
611 BLOOD POTASSIUM DECREASED 1 0.0000
612 PLEURAL EFFUSION 2 0.0000
613 EMOTIONAL DISORDER 1 0.0000
614 PULMONARY EMBOLISM 3 0.0000
615 CYSTITIS 1 0.0000
616 MOOD SWINGS 1 0.0000
617 LACTIC ACIDOSIS 1 0.0000
618 HEART RATE INCREASED 3 0.0000
619 RENAL FAILURE 4 0.0000
620 MYALGIA 5 0.0000
621 HAEMOGLOBIN DECREASED 3 0.0000
622 BURNING SENSATION 2 0.0000
623 HYPERKALAEMIA 1 0.0000
624 HYPOXIA 1 0.0000
625 SKIN BURNING SENSATION 2 0.0000
626 DYSURIA 1 0.0000
627 COLITIS 1 0.0000
628 BLOOD PRESSURE INCREASED 4 0.0000
629 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
630 DISORIENTATION 1 0.0000
631 FEELING ABNORMAL 6 0.0000
632 CARDIAC FAILURE CONGESTIVE 2 0.0000
633 CARDIAC ARREST 2 0.0000
634 POLLAKIURIA 1 0.0000
635 RENAL FAILURE ACUTE 1 0.0000
636 CONSTIPATION 5 0.0000
637 PULMONARY OEDEMA 1 0.0000
638 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
639 SKIN DISCOLOURATION 1 0.0000
640 PRODUCTIVE COUGH 1 0.0000
641 BLOOD GLUCOSE DECREASED 1 0.0000
642 HYPOGLYCAEMIA 1 0.0000
643 ATRIAL FIBRILLATION 2 0.0000
644 CELLULITIS 1 0.0000
645 NERVOUSNESS 1 0.0000
646 HAEMATOCHEZIA 1 0.0000
647 OXYGEN SATURATION DECREASED 1 0.0000
648 PALPITATIONS 2 0.0000
649 SUICIDE ATTEMPT 1 0.0000
650 ANAEMIA 3 0.0000
651 BLOOD CREATININE INCREASED 1 0.0000
652 FEBRILE NEUTROPENIA 1 0.0000
653 BLOOD PRESSURE DECREASED 1 0.0000
654 INJECTION SITE PRURITUS 1 0.0000
655 RESPIRATORY FAILURE 1 0.0000
656 DYSGEUSIA 1 0.0000
657 HALLUCINATION 1 0.0000
658 ACNE 1 0.0000
659 INJECTION SITE BRUISING 1 0.0000
660 TREMOR 2 0.0000
661 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
662 BALANCE DISORDER 1 0.0000
663 SUICIDAL IDEATION 1 0.0000
664 CARDIAC DISORDER 1 0.0000
665 DYSPHAGIA 1 0.0000
666 SYNCOPE 1 0.0000
667 CHEST DISCOMFORT 1 0.0000
668 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
669 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
670 DEHYDRATION 1 0.0000
671 VISION BLURRED 1 0.0000
672 DRUG INTERACTION 1 0.0000
673 URINARY TRACT INFECTION 1 0.0000
674 COUGH 1 0.0000
675 PRODUCT DOSE OMISSION ISSUE 1 0.0000
676 INJECTION SITE PAIN 1 0.0000